BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15515545)

  • 1. [Expression of p15 protein in poorly differentiated nasopharyngeal carcinoma].
    Liang C; Zhang F; Zeng X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):591-3. PubMed ID: 15515545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
    Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
    Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
    Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
    Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Wei J; Huang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
    Cui D; Zhang X; Fu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of proliferating cell nuclear antigen and Bcl-2 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Huang X; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Apr; 17(4):217-9. PubMed ID: 12838865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of vascular endothelial growth factor in nasopharyngeal carcinoma].
    Zhao SP; Wang CL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):114-6. PubMed ID: 12934350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of suppressor gene p16, p21 and p53 in nasopharyngeal carcinoma].
    Lei X; Zhou Y; He X; Chen F
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Sep; 13(9):406-8. PubMed ID: 12541388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG; Xiang XJ; He YJ
    Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of DLC1 gene expression in nasopharyngeal carcinoma].
    Peng H; Zhao T; Yao K
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 37(6):454-7. PubMed ID: 12966809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of human nuclear distribution C in nasopharyngeal carcinoma].
    Chen Y; Yang Y; Lin Z; Peng H; Lu H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):71-3. PubMed ID: 21473139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoplasmic expression of P27 protein and its correlation with clinicopathologic features of nasopharyngeal carcinoma].
    Hang W; Sun S; Ye Y; Fang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):882-4. PubMed ID: 23803203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between expression of estrogen receptor progestrone receptor and the biological characteristics of nasopharyngeal carcinoma].
    Xu B; Hu P; Wu Q; Hou J; Zhang B; Chen X; Huang G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 13(8):347-9. PubMed ID: 12541358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.